SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of building a blockbuster with an expansion into another seizures subtype. Now, ...
Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...
The American Academy of Neurology (AAN) has released its first guideline for the management of functional seizures, providing clinicians with timely recommendations on treating the commonly ...